202 related articles for article (PubMed ID: 25691441)
1. Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases.
Le Pennec S; Konopka T; Gacquer D; Fimereli D; Tarabichi M; Tomás G; Savagner F; Decaussin-Petrucci M; Trésallet C; Andry G; Larsimont D; Detours V; Maenhaut C
Endocr Relat Cancer; 2015 Apr; 22(2):205-16. PubMed ID: 25691441
[TBL] [Abstract][Full Text] [Related]
2. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
3. Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.
Rubinstein JC; Brown TC; Christison-Lagay ER; Zhang Y; Kunstman JW; Juhlin CC; Nelson-Williams C; Goh G; Quinn CE; Callender GG; Udelsman R; Lifton RP; Korah R; Carling T
BMC Cancer; 2016 Aug; 16():646. PubMed ID: 27538953
[TBL] [Abstract][Full Text] [Related]
4. Functional loss of tumor suppressor genes detected by loss of heterozygosity, but not driver mutations, predicts aggressive lymph node status in papillary thyroid carcinoma.
Finkelstein S; Timmaraju VA; Samankan S; O'Malley Q; Kapustin D; Spaulding S; Xing M; Matloob A; Beute J; Seo G; Saturno M; Greenberg L; Wein L; Gonzalez-Velazquez C; Doyle S; Levine J; Urken M; Brandwein-Weber M
Pathol Res Pract; 2023 Nov; 251():154842. PubMed ID: 37890270
[TBL] [Abstract][Full Text] [Related]
5. BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis.
Walts AE; Pao A; Sacks W; Bose S
Hum Pathol; 2014 May; 45(5):935-41. PubMed ID: 24746198
[TBL] [Abstract][Full Text] [Related]
6. Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
Xia M; Li H; Ma Q; Yu D; Li J; Zhang Y; Sheng Y; Guo Y
Cancer Lett; 2017 Jun; 396():110-116. PubMed ID: 28315434
[TBL] [Abstract][Full Text] [Related]
7. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
[TBL] [Abstract][Full Text] [Related]
9. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
[TBL] [Abstract][Full Text] [Related]
10. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK
Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443
[TBL] [Abstract][Full Text] [Related]
11. TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.
Melo M; Gaspar da Rocha A; Batista R; Vinagre J; Martins MJ; Costa G; Ribeiro C; Carrilho F; Leite V; Lobo C; Cameselle-Teijeiro JM; Cavadas B; Pereira L; Sobrinho-Simões M; Soares P
J Clin Endocrinol Metab; 2017 Jun; 102(6):1898-1907. PubMed ID: 28323937
[TBL] [Abstract][Full Text] [Related]
12. The Role of SPECT/CT Lymphoscintigraphy and Radioguided Sentinel Lymph Node Biopsy in Managing Papillary Thyroid Cancer.
Cabrera RN; Chone CT; Zantut-Wittmann DE; Matos PS; Ferreira DM; Pereira PS; Ribeiro MP; Santos AO; Ramos CD; Crespo AN; Etchebehere EC
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):834-41. PubMed ID: 27366869
[TBL] [Abstract][Full Text] [Related]
13. Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles.
Lu Z; Sheng J; Zhang Y; Deng J; Li Y; Lu A; Zhang J; Yu H; Zhang M; Xiong Z; Yan H; Diplas BH; Lu Y; Liu B
J Pathol; 2016 May; 239(1):72-83. PubMed ID: 27071483
[TBL] [Abstract][Full Text] [Related]
14. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma].
Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398
[TBL] [Abstract][Full Text] [Related]
15. Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon.
Xu B; Scognamiglio T; Cohen PR; Prasad ML; Hasanovic A; Tuttle RM; Katabi N; Ghossein RA
Hum Pathol; 2017 Jul; 65():133-139. PubMed ID: 28552827
[TBL] [Abstract][Full Text] [Related]
16. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
17. Differentiating the location of cervical lymph node metastasis is very useful for estimating the risk of distant metastases in papillary thyroid carcinoma.
Jeon MJ; Kim TY; Kim WG; Han JM; Jang EK; Choi YM; Song DE; Yoon JH; Chung KW; Hong SJ; Shong YK; Kim WB
Clin Endocrinol (Oxf); 2014 Oct; 81(4):593-9. PubMed ID: 24750108
[TBL] [Abstract][Full Text] [Related]
18. BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma.
Givens DJ; Buchmann LO; Agarwal AM; Grimmer JF; Hunt JP
Laryngoscope; 2014 Sep; 124(9):E389-93. PubMed ID: 24604709
[TBL] [Abstract][Full Text] [Related]
19. Do black (dark) lymph-node metastases in papillary thyroid carcinoma suggest more advanced or aggressive disease?
Crist HS; Evans JJ; Mani H; Saunders B; Fornadley J; Camacho F; Goldenberg D
Thyroid; 2013 Aug; 23(8):977-81. PubMed ID: 23343222
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary study of patterns of level IIb lymph node metastasis in papillary thyroid carcinoma].
Wan H; Zhang B; Liu S; Li Z; Wu Y; Wang X; Xu Z; Tang P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 49(1):27-30. PubMed ID: 24680333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
